3-62372376-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_018008.4(FEZF2):​c.493G>A​(p.Ala165Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,611,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

FEZF2
NM_018008.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.65
Variant links:
Genes affected
FEZF2 (HGNC:13506): (FEZ family zinc finger 2) Predicted to enable transcription cis-regulatory region binding activity. Predicted to be involved in positive regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including negative regulation of transcription by RNA polymerase II; nervous system development; and regulation of neuron differentiation. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037348658).
BS2
High AC in GnomAd4 at 23 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FEZF2NM_018008.4 linkuse as main transcriptc.493G>A p.Ala165Thr missense_variant 2/5 ENST00000283268.8 NP_060478.3 Q8TBJ5-1A0A140VKG3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FEZF2ENST00000283268.8 linkuse as main transcriptc.493G>A p.Ala165Thr missense_variant 2/51 NM_018008.4 ENSP00000283268.3 Q8TBJ5-1
FEZF2ENST00000475839.1 linkuse as main transcriptc.493G>A p.Ala165Thr missense_variant 1/41 ENSP00000418804.1 Q8TBJ5-1
FEZF2ENST00000486811.5 linkuse as main transcriptc.493G>A p.Ala165Thr missense_variant 3/65 ENSP00000418589.1 Q8TBJ5-1

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152174
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000577
AC:
14
AN:
242602
Hom.:
0
AF XY:
0.0000602
AC XY:
8
AN XY:
132880
show subpopulations
Gnomad AFR exome
AF:
0.000400
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000113
Gnomad SAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000274
AC:
40
AN:
1459008
Hom.:
0
Cov.:
32
AF XY:
0.0000262
AC XY:
19
AN XY:
725968
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000929
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.000315
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152174
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74328
show subpopulations
Gnomad4 AFR
AF:
0.000555
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000680
Hom.:
0
Bravo
AF:
0.000166
ESP6500AA
AF:
0.000457
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000661
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 22, 2023The c.493G>A (p.A165T) alteration is located in exon 2 (coding exon 1) of the FEZF2 gene. This alteration results from a G to A substitution at nucleotide position 493, causing the alanine (A) at amino acid position 165 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.19
T;T;T
Eigen
Benign
-0.18
Eigen_PC
Benign
0.013
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.72
.;.;T
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.037
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.0
L;L;L
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.066
Sift
Benign
0.20
T;T;T
Sift4G
Benign
0.21
T;T;T
Polyphen
0.010
B;B;B
Vest4
0.095
MVP
0.15
MPC
1.2
ClinPred
0.037
T
GERP RS
5.2
Varity_R
0.16
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372346060; hg19: chr3-62358051; API